BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 25352456)

  • 1. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
    Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
    J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease.
    Ying M; Sui X; Zhang Y; Sun Q; Qu Z; Luo X; Chang RC; Ni J; Liu J; Yang X
    Mol Neurobiol; 2017 Jul; 54(5):3843-3858. PubMed ID: 27335030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease.
    Yu H; Wang D; Zou L; Zhang Z; Xu H; Zhu F; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Yang X
    Arch Toxicol; 2018 Apr; 92(4):1363-1382. PubMed ID: 29383422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease.
    Nie L; Wei G; Peng S; Qu Z; Yang Y; Yang Q; Huang X; Liu J; Zhuang Z; Yang X
    Biofactors; 2017 Jul; 43(4):593-611. PubMed ID: 28608594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
    J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
    Guzmán-Ramos K; Moreno-Castilla P; Castro-Cruz M; McGaugh JL; Martínez-Coria H; LaFerla FM; Bermúdez-Rattoni F
    Learn Mem; 2012 Sep; 19(10):453-60. PubMed ID: 22984283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease.
    Nie L; Xia J; Li H; Zhang Z; Yang Y; Huang X; He Z; Liu J; Yang X
    Oxid Med Cell Longev; 2017; 2017():6473506. PubMed ID: 29204248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
    Fertan E; Wong AA; Vienneau NA; Brown RE
    Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
    Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
    Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models.
    Neuner SM; Wilmott LA; Hoffmann BR; Mozhui K; Kaczorowski CC
    Behav Brain Res; 2017 Mar; 322(Pt B):288-298. PubMed ID: 27265785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
    Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
    Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
    Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms.
    García-Mesa Y; Pareja-Galeano H; Bonet-Costa V; Revilla S; Gómez-Cabrera MC; Gambini J; Giménez-Llort L; Cristòfol R; Viña J; Sanfeliu C
    Psychoneuroendocrinology; 2014 Jul; 45():154-66. PubMed ID: 24845186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
    Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ
    Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.